🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the clinical study is to evaluate the tolerability, safety...
Status
Completed
Location
State Budgetary Healthcare Institution of the Moscow region - Krasnogorsk City Hospital # 1 (short name: SBHI MR KCH # 1)
Start Date
2020-11-27
Trial ID
NCT04780035
Part I: 12 subjects will receive an open-label 500 µl subcutaneous injecti...
Status
Completed
Location
University Hospital Tuebingen
Start Date
2020-11-27
Trial ID
NCT04546841
Treatments Being Tested
The primary objective of this study is to evaluate how implementing an inno...
Status
Completed
Location
Walmart Pharmacy
Start Date
2017-12-12
Trial ID
NCT03372967
The immunogenicity and safety of AdCLD-CoV19-1 OMI (5.0x10\^10 VP (0.5 mL)/...
Status
Active Not Recruiting
Location
The Medical City-Iloilo
Start Date
2023-11-27
Trial ID
NCT05993325
Treatments Being Tested
Administration of DPX-RSV(A), a Respiratory Syncytial Virus vaccine contain...
Status
Completed
Location
IWK Health Centre
Start Date
2015-05
Trial ID
NCT02472548
Treatments Being Tested
The effectiveness of a vaccine can be improved by using a "prime boost stra...
Status
Completed
Location
Alabama Vaccine CRS
Start Date
2004-04
Trial ID
NCT00076037
Treatments Being Tested
Description: A randomized Placebo-controlled study to evaluate safety and e...
Status
Unknown
Location
National Liver Institute, Menofyia University
Start Date
2011-03
Trial ID
NCT01718834
Treatments Being Tested
Aim: In a phase II pilot study encompassing 20 patients with Graves' disea...
Status
Completed
Location
Department of Endocrinology, Odense University Hospital
Start Date
2003-06
Trial ID
NCT00150111
Treatments Being Tested
Originally, the study was planned to include two parts, i.e., Part A and Pa...
Status
Completed
Location
Contract Research Organization
Start Date
2020-04-23
Trial ID
NCT04380701
To evaluate safety and immunogenicity of 2 different HIV-1 peptide candidat...
Status
Completed
Location
Univ of Alabama at Birmingham
Start Date
TBD
Trial ID
NCT00000846
Treatments Being Tested